ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,064.20
0.91%
Dow Jones
38,225.66
0.85%
US Dollar vs MXN
16.98221
0.23%
Brent Oil
83.63
0.11%
Bitcoin
59,342.69
1.90%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Femasys Inc (FEMY)

  7. Femasys Inc (FEMY) Noticias

FEMY

Femasys (FEMY)

Femasys Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:FEMY
FechaHoraFuenteTítuloSímboloCompañía
18/04/202407:30GlobeNewswire Inc.Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare InitiativesNASDAQ:FEMYFemasys Inc
28/03/202415:05GlobeNewswire Inc.Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate UpdateNASDAQ:FEMYFemasys Inc
21/03/202408:00GlobeNewswire Inc.Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment LandscapeNASDAQ:FEMYFemasys Inc
20/03/202407:15GlobeNewswire Inc.Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of InfertilityNASDAQ:FEMYFemasys Inc
13/03/202408:00GlobeNewswire Inc.Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024NASDAQ:FEMYFemasys Inc
06/03/202408:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
06/03/202408:00GlobeNewswire Inc.Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility SolutionNASDAQ:FEMYFemasys Inc
13/02/202420:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
13/02/202420:44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
10/12/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FEMYFemasys Inc
08/12/202308:28Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FEMYFemasys Inc
30/11/202316:17Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FEMYFemasys Inc
22/11/202315:12Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:FEMYFemasys Inc
15/11/202307:30Business WirePharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.NASDAQ:FEMYFemasys Inc
10/08/202307:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FEMYFemasys Inc
07/08/202307:40Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:FEMYFemasys Inc
28/07/202316:15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:FEMYFemasys Inc
07/07/202315:26Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:FEMYFemasys Inc
26/06/202307:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FEMYFemasys Inc
16/06/202315:37Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FEMYFemasys Inc
16/05/202315:37Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FEMYFemasys Inc
15/05/202305:29Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:FEMYFemasys Inc
15/05/202305:29Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FEMYFemasys Inc
05/05/202315:02Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:FEMYFemasys Inc
28/04/202305:17Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:FEMYFemasys Inc
20/04/202308:40Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:FEMYFemasys Inc
05/04/202315:03Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FEMYFemasys Inc
30/03/202307:50Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FEMYFemasys Inc
01/12/202214:15TipRanksMaxim Group Keeps Their Buy Rating on Femasys (FEMY)NASDAQ:FEMYFemasys Inc
13/11/202208:30TipRanksAnalysts’ Top Technology Picks: AppLovin (APP), Femasys (FEMY)NASDAQ:FEMYFemasys Inc
 Showing the most relevant articles for your search:NASDAQ:FEMY

Su Consulta Reciente

SPI
SP500
S&P 500
USOTC
BNPQY
BNP Paribas (QX)
NYSE
XOM
Exxon Mobil
NYSE
MCD
McDonalds
USI
USTECH100
US Tech 100
FX
USDMXN
US Dollar vs MXN
USOTC
RHHBY
Roche (QX)
NYSE
VZ
Verizon Communications
AMEX
SPY
SPDR S&P 500
NYSE
AXP
American Express
USOTC
DTEGY
Deutsche Telekom (QX)
COIN
ETHUSD
Ethereum
USOTC
BASFY
BASF (QX)
PM
XAUUSD
Gold vs US Dollar
NYSE
BAC
Bank of America
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados